Oral Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Pratley, Richard E.; Crowley, Matthew J.; Gislum, Mette; Hertz, Christin L.; Jensen, Thomas B.; Khunti, Kamlesh; Mosenzon, Ofri; Buse, John B.

authors

Publication Date

  • March 4, 2021

webpage

published in

category

keywords

  • Diabetes mellitus
  • Glucagon-like peptides
  • Hypoglycaemic agents
  • Insulin
  • Metformin
  • Oral semaglutide
  • Sodium-glucose cotransporter 2 inhibitors
  • Sulphonylurea compounds
  • type 2

start page

  • 1099

end page

  • 1116

volume

  • 12

issue

  • 4